News Sentiment

SYK sentiment intelligence

Stryker Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 58 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 329.78 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 7

high-authority source matches

Trend context Trend inactive

+1.0% over one week, +5.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Stryker Corp (XTER:SYK) Stock Price, Trades & News

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 1.0% Price digesting
Trend fit Trend inactive 5.9% over four weeks
Fair value -3.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 36
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 11
Sector context 2

Sources

Coverage mix

Publishers
Market source 14
simplywall.st 5
Stock Titan 4
GuruFocus 3
Simply Wall Street 3
The Economic Times 3
MarketWatch 2
Quiver Quantitative 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 17
Analyst action 3
Macro sensitivity 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
GuruFocus Direct company coverage

Stryker Corp (XTER:SYK) Stock Price, Trades & News

This page provides comprehensive financial data, news, and analysis for Stryker Corp (XTER:SYK), a medical equipment manufacturer. It details current stock price, market cap, various financial ratios, growth rates, profitability ranks, and upcoming earnings dates. The company des

Tone
Positive 73/100
Event
Earnings
Published
16 Jul 2026 20:09
Source
GuruFocus
MarketWatch Direct company coverage

Stryker Corp. stock outperforms competitors on strong trading day

Stryker Corp. (SYK) shares rose 4.66% to $331.20 on Thursday, outperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average decline. This marks the second consecutive day of gains for the company's stock. The positive performance occurred during an

Tone
Positive 72/100
Event
Market update
Published
16 Jul 2026 16:36
Source
MarketWatch
Investing News Network Direct company coverage

Stryker expands Mako robotics portfolio with full market release of Mako RPS

Stryker has launched Mako RPS (Robotic Power System) for total knee replacement, expanding its Mako robotics portfolio with new handheld technology. This system combines robotic execution with a familiar handheld power tool workflow, aiming to broaden access to robotic-assisted k

Tone
Positive 70/100
Event
Market update
Published
16 Jul 2026 15:17
Source
Investing News Network
Simply Wall Street Direct company coverage

Stryker (SYK) Cyberattack Puts Its Undervalued Narrative To The Test

Stryker (SYK) is facing scrutiny after a cyberattack by Iranian hackers caused disruptions, temporarily halting order processing and production worldwide. Despite a recent share price rise, its year-to-date and one-year returns are negative, suggesting the cyberattack and softer

Tone
Negative 39/100
Event
Market update
Published
16 Jul 2026 14:42
Source
Simply Wall Street
Financial Times Direct company coverage

Stryker expands Mako robotics portfolio with full market release of Mako RPS – Company Announcement

Stryker has announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures, expanding its Mako robotics portfolio. This new handheld robotics platform offers surgeons an intuitive experience and integrates with Stryker's Triathlon To

Tone
Positive 74/100
Event
Market update
Published
16 Jul 2026 13:05
Source
Financial Times
Stock Titan Direct company coverage

Stryker Reports More Than 2.5M Mako Procedures in 47 Countries

Stryker (NYSE: SYK) has announced the U.S. commercial launch of its Mako RPS (Robotic Power System) for total knee replacement, expanding its Mako portfolio into a new category of handheld orthopaedic robotics. This system combines intraoperative planning with a robotically enabl

Tone
Positive 71/100
Event
Market update
Published
16 Jul 2026 13:05
Source
Stock Titan
Simply Wall Street Direct company coverage

Can Stryker (SYK) Turn Nerve Repair Biomaterials Into a Core Neurotechnology Growth Engine?

Stryker (SYK) is positioned to leverage rapid growth in the nerve repair biomaterials sector, which could enhance its neurotechnology portfolio and international expansion, particularly in Asia-Pacific. The company's investment narrative projects significant revenue and earnings

Tone
Positive 72/100
Event
Earnings
Published
15 Jul 2026 02:30
Source
Simply Wall Street
GuruFocus Direct company coverage

Stryker Corp (SYK) Stock Down 6.2% -- Now Undervalued? GF Score: 92/100

Stryker Corp (SYK) shares recently fell 6.2% to $311.07, marking an 11.0% year-to-date drop. Despite this, GuruFocus.com indicates the stock is Modestly Undervalued with a GF Value™ estimate of $413.10 and a strong GF Score™ of 92/100. However, significant insider selling totalin

Tone
Negative 39/100
Event
Market update
Published
14 Jul 2026 21:39
Source
GuruFocus
TradingKey Direct company coverage

Stryker Corp Stock (SYK) Moved Down by 5.49% on Jul 14: A Full Analysis

Stryker Corp (SYK) stock declined by 5.49% due to concerns over decelerating hospital capital equipment spending, increased competition in the orthopedic market, and macroeconomic factors like labor inflation. Analysts cited limited upside potential and a challenging reimbursemen

Tone
Negative 29/100
Event
Macro sensitivity
Published
14 Jul 2026 19:15
Source
TradingKey
Seeking Alpha Sector context

MedTech stocks lower as HCA surgery volumes dip (HCA:NYSE)

MedTech stocks experienced a downturn following HCA Healthcare's announcement of lowered full-year earnings outlook and a preliminary Q2 2026 report indicating a drop in surgical procedures. This decline in surgical volumes at the largest for-profit hospital operator in the U.S.

Tone
Negative 29/100
Event
Earnings
Published
14 Jul 2026 18:40
Source
Seeking Alpha
TechStock² Sector context

Intuitive Surgical (NASDAQ:ISRG) slides 6%; HCA surgery slowdown sharpens Q2 valuation test

Intuitive Surgical (ISRG) shares dropped 6.2% following HCA Healthcare's report of a slowdown in surgical volumes, raising concerns about ISRG's upcoming Q2 results. Despite analyst target cuts, the stock's valuation remains premium, reflecting expectations for continued growth,

Tone
Negative 28/100
Event
Analyst action
Published
14 Jul 2026 17:49
Source
TechStock²
MarketWatch Direct company coverage

Stryker Corp. stock underperforms Tuesday when compared to competitors

Stryker Corp. (SYK) shares fell by 6.15% to $311.07 on Tuesday, underperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average rise. This decline ended a three-day winning streak for the company's stock.

Tone
Negative 29/100
Event
Market update
Published
14 Jul 2026 16:30
Source
MarketWatch
concentratemedia Direct company coverage

Stryker acquires U-M arterial disease treatment startup for $835 million

Stryker, a Portage-based medical tech company, has acquired Amplitude Vascular Systems (AVS), a University of Michigan startup, for $835 million. AVS developed the Pulse Intravascular Lithotripsy (IVL) system, which uses hydraulic pulse waves to break down calcium buildup in arte

Tone
Positive 71/100
Event
Market update
Published
14 Jul 2026 14:32
Source
concentratemedia
www.marketscreener.com Direct company coverage

Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating

Goldman Sachs has updated its price target for Stryker (SYK) to $339, down from the previous $363, while maintaining a Neutral rating on the stock. This adjustment reflects the firm's latest assessment of the medical equipment company. Other analysts have also recently modified t

Tone
Negative 39/100
Event
Analyst action
Published
14 Jul 2026 11:33
Source
www.marketscreener.com
Simply Wall Street Direct company coverage

3 US Healthcare Stocks Investors May Revisit As Inflation Pressures Build

As inflation pressures build and crude/polypropylene costs rise, investors are looking for defensive large-cap stocks. This article identifies three U.S. healthcare stocks—Abbott Laboratories (ABT), ResMed (RMD), and Stryker (SYK)—that offer essential products and services, makin

Tone
Neutral 50/100
Event
Macro sensitivity
Published
13 Jul 2026 08:47
Source
Simply Wall Street